Trial Profile
A randomized controlled study comparing Anastrozole+TS-1 as postoperative chemotherapy in ER positive metastatic breast cancer
Status:
Discontinued
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 08 Jun 2009
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms TACS
- 08 Jun 2009 New trial record.